The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Aspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage
Abstract
Despite intensive investigation, an underlying cause of miscarriage has not been found in a high proportion of women with a history of recurrent miscarriage. No effective intervention has been identified that improves rates of live birth. Some investigators have suggested that treatment of women with unexplained recurrent miscarriage with aspirin and low-molecular-weight heparin may increase the proportion of live births; the limited data available from randomized controlled trials have been inconsistent. This multicenter, randomized, placebo-controlled trial investigated whether a combination of aspirin with low-molecular-weight heparin or aspirin alone, compared with placebo, would improve the live-birth rate in women with a history of unexplained recurrent miscarriage. The study subjects were 364 women aged 18 to 42 years with a history of unexplained recurrent miscarriage who were trying to conceive or were pregnant less than 6 weeks. Women were randomly assigned to receive combined therapy (n = 123) consisting of daily doses of aspirin 80 mg plus open-label subcutaneous low-molecular-weight heparin (nadroparin) at a dose of 2850 IU, or 80 mg of aspirin alone (n = 120), or placebo (n = 121) either before conception or at a gestational age of less than 6 weeks. The main study outcome measure was the rate of live birth. Secondary outcome measures included rates of miscarriage, obstetrical complications, and maternal and neonatal adverse events. No significant difference between the 3 study groups was found in the proportion of live births (combined therapy, 54.5%; aspirin only, 50.8%; and placebo, 57%); the absolute difference in live-birth rate for combined therapy versus placebo was −2.6 percentage points, with a 95% confidence interval of −15.0 to 9.9; and for the aspirin only versus placebo was −6.2, with a 95% confidence interval of −18.8 to 6.4 (P = 0.63). There was also no significant difference in the live-birth rates among the 299 women in these 3 groups who became pregnant; the rates were 69.1% in the combined therapy group, 61.6% in the aspirin-only group, and 67.0% in the placebo group (P = 0.52). Compared to the other 2 groups, the combined therapy group had a significantly increased tendency for bruising and swelling or itching at the injection site (P < 0.001). These findings demonstrate that neither aspirin combined with nadroparin nor aspirin alone increase the likelihood of a live birth in comparison with placebo among women with unexplained recurrent miscarriage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson, M. B., Lassere, M., Craig, J. C., & Scott, J. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002859.pub2 · Cited by 486
Kaandorp, S. P., Nisio, M. D., Goddijn, M., & Middeldorp, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004734.pub3 · Cited by 128
Self-citationInherited Thrombophilia and Pregnancy Complications Revisited
Rodger, M. A., Paidas, M. J., Claire, M., et al. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000350593.51711.a4 · Cited by 42
Recurrent spontaneous pregnancy loss. Investigation and reproductive follow-up.
Dm, G., Je, L., Ja, H., & Wilson, R. D. (1991) · PubMed · Cited by 15
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Self-citationCyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
Recurrent pregnancy loss: current perspectives
El Hachem, H., Crepaux, V., May-Panloup, P., Descamps, P., Legendre, G., & Bouet, P.-E. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s100817 · Cited by 462
Branch, D. W., Gibson, M., & Silver, R. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1005330 · Cited by 326
Metadata
- Authors
- Kaandorp, S. P., Goddijn, M., van der Post, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyák, K., Willem Mol, B., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., Büller, H. R., van der Veen, F., & Middeldorp, S.
- Venue
- Obstetrical & Gynecological Survey
- Published
- 2010-10
- Volume
- 65
- Issue
- 10
- Pages
- 621-622
- ISSN
- 0029-7828 (ISSN-L)
- OpenAlex
- W4231905096
- Cited by
- 364
- References
- 4
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage. https://app.cochat.ai/papers/10.1097/ogx.0b013e3182021f71
- The paper
- Kaandorp, S. P., Goddijn, M., van der Post, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyák, K., Willem Mol, B., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., Büller, H. R., van der Veen, F., & Middeldorp, S. (2010). Aspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage. Obstetrical & Gynecological Survey. https://doi.org/10.1097/ogx.0b013e3182021f71
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.